Shopping Cart
- Remove All
- Your shopping cart is currently empty
Almokalant is a class III antiarrhythmic drug, acts as a potassium channel blocker. And it inhibits a specific component (Ikr) of the time-dependent delayed rectifier K+ current.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,520 | 6-8 weeks | |
50 mg | $1,980 | 6-8 weeks | |
100 mg | $2,500 | 6-8 weeks |
Description | Almokalant is a class III antiarrhythmic drug, acts as a potassium channel blocker. And it inhibits a specific component (Ikr) of the time-dependent delayed rectifier K+ current. |
In vitro | Almokalant, a class III antiarrhythmic drug, functions as a potassium channel blocker, inhibiting the specific (Ikr) component of the time-dependent delayed rectifier K+ current. |
In vivo | Almokalant (125 μmol/kg, p.o.) administered on Day 11 of pregnancy induces cardiovascular defects, orofacial clefts, and tail defects in pregnant rats. |
Alias | H 234/09 |
Molecular Weight | 352.49 |
Formula | C18H28N2O3S |
Cas No. | 123955-10-2 |
Relative Density. | 1.31g/cm3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.